Literature DB >> 14757442

Familial (inherited) leukemia, lymphoma, and myeloma: an overview.

George B Segel1, Marshall A Lichtman.   

Abstract

We have reviewed the world's literature that addresses familial leukemia, lymphoma, and myeloma. We have catalogued the phenotypic abnormalities associated with an increased risk of developing a hematological malignancy. These syndromes, such as Fanconi anemia or familial platelet syndrome, have been well characterized and in many cases the gene responsible for the predisposition has been defined. We have focused, however, on reports of a familial incidence of hematological malignancy in which no prior predisposing syndrome was reported. In this circumstance, so-called pure familial leukemia, lymphoma, or myeloma, the intergenerational incidence of disease occurred in ostensibly healthy persons. These families have been grouped into sets in which (a) anticipation, (b) immune abnormalities, (c) linkage to HLA phenotypes, (d) linkage to chromosome abnormalities, or (e) gene abnormalities have been reported. They have also been grouped by type of leukemia. Purely descriptive reports, not accompanied by some information on pathogenesis, have not been included. They are catalogued in some of the references cited in this paper. Anticipation is a prominent feature of familial leukemia, lymphoma, and myeloma, supporting the concept of germline transmission of a susceptibility gene. Although linkage to an HLA phenotype occurs in some families, no consistent intrafamilial pattern has emerged. Deletion of chromosome 7 is associated with familial acute myelogenous leukemia, but no other recurring localization has been established. Although putative susceptibility genes have been identified in some families, the likelihood is that the mode of inheritance is different in different families and different genes are involved even within a specific Mendelian pattern. Although as yet not reported, the frequency of familial CLL and the intensity of its study indicates that the gene or genes involved in that familial disorder(s) should be identified conclusively soon if sufficient families for study can be assembled through international cooperation.

Entities:  

Mesh:

Year:  2004        PMID: 14757442     DOI: 10.1016/j.bcmd.2003.10.005

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  13 in total

Review 1.  Familial predisposition and genetic risk factors for lymphoma.

Authors:  James R Cerhan; Susan L Slager
Journal:  Blood       Date:  2015-09-24       Impact factor: 22.113

2.  The influence of parental age and gender on anticipation in familial B-cell malignancies.

Authors:  Doru T Alexandrescu; Peter H Wiernik
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

3.  The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma.

Authors:  Brian C-H Chiu; Qing Lan; Bhavana J Dave; Aaron Blair; Shelia Hoar Zahm; Dennis D Weisenburger
Journal:  J Natl Cancer Inst Monogr       Date:  2008

Review 4.  Host genetics in follicular lymphoma.

Authors:  James R Cerhan
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-05       Impact factor: 3.020

5.  BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families.

Authors:  Ana Peixoto; Natália Salgueiro; Catarina Santos; Graça Varzim; Patrícia Rocha; Maria José Soares; Deolinda Pereira; Helena Rodrigues; Maria José Bento; António Fráguas; Graça Moura; Fernando Regateiro; Sérgio Castedo; Manuel R Teixeira
Journal:  Fam Cancer       Date:  2006-07-07       Impact factor: 2.375

Review 6.  Case-only exome sequencing and complex disease susceptibility gene discovery: study design considerations.

Authors:  Lang Wu; Daniel J Schaid; Hugues Sicotte; Eric D Wieben; Hu Li; Gloria M Petersen
Journal:  J Med Genet       Date:  2014-11-04       Impact factor: 6.318

Review 7.  Predispositions to Lymphoma: A Practical Review for Genetic Counselors.

Authors:  Morgan Similuk; V Koneti Rao; Jane Churpek; Michael Lenardo
Journal:  J Genet Couns       Date:  2016-06-06       Impact factor: 2.537

Review 8.  Genetic susceptibility to lymphoma.

Authors:  Christine F Skibola; John D Curry; Alexandra Nieters
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941

9.  Heritable T-cell malignancy models established in a zebrafish phenotypic screen.

Authors:  J K Frazer; N D Meeker; L Rudner; D F Bradley; A C H Smith; B Demarest; D Joshi; E E Locke; S A Hutchinson; S Tripp; S L Perkins; N S Trede
Journal:  Leukemia       Date:  2009-06-11       Impact factor: 11.528

10.  Familial multiple myeloma: report on two families and discussion of screening options.

Authors:  Erica H Gerkes; Mirjam M de Jong; Rolf H Sijmons; Edo Vellenga
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.